In focus
MoleculeMind report details MMDesign results across nanobodies and macrocyclic peptides
MoleculeMind has released a technical report on MMDesign, its AI-powered de novo molecular design platform, citing a 94.7% campaign success rate across 19 design campaigns spanning 18 targets and two molecular modalities. The report also compares its MMFold structure prediction model with AlphaFold 3 on the FoldBench benchmark.
Read the story